Household smoking cessation in children with Cystic Fibrosis and Asthma
Research type
Research Study
Full title
Household smoking cessation in children with Cystic Fibrosis and Asthma in North Yorkshire – From which can we learn more?
IRAS ID
182339
Contact name
Dominic O'Reilly
Contact email
Sponsor organisation
University of Leeds
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
An estimated 9.4million UK adults (18.7% of the population) currently smoke cigarettes. Smoking is inherently harmful to the lungs and airways of adults and children alike. Environental tobacco smoke (ETS) exposure is particularly damaging to children with chronic lung diseases such as asthma and cystic fibrosis.
We will prospectively collect consent and smoking data from families of children attending outpatient clinics with a diagnosis of cystic fibrosis or asthma over a 6 month period across three sites, Leeds General Infirmary, Bradford Royal Infirmary and Hull Royal Infirmary. We will provide questionnaires to families who consent in clinic appointments, with requests to fill these out during clinic appointment waits (with the secondary option of taking them home to complete and return by stamped-addressed envelope).
We will also collect retrospective data from notes, regarding consultations at the time of diagnosis and from subsequent clinic reviews, on household smoking and use of cessation aids, on completion and return of the related questionnaire. Where smoking cessation has taken place, we will collect data on stage of disease at the point where cessation was undertaken and where it was successful. We will analyse the data and assess whether there is a difference between both diagnostic groups. We suspect both groups will be equally successful in smoking cessation.REC name
South East Scotland REC 01
REC reference
15/SS/0178
Date of REC Opinion
19 Oct 2015
REC opinion
Further Information Favourable Opinion